Avant Immunotherapeutics

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a broad portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines aimed a protecting travelers from cholera, typhoid fever and other illnesses. In addition, the company is conducting clinical studies of a proprietary vaccine candidate for cholesterol management. AVANT further leverages the value of its technology portfolio through corporate partnerships. Current collaborations encompass the development of an oral human rotavirus vaccine, vaccines to combat threats of biological warfare, and vaccines addressed to human food safety and animal health.

Contact Details: 119 Fourth Avenue Needham 02494 United States of America Tel: 781 433 0771 Fax: 781 433 0262 Email: info@avantimmune.com WWW: www.avantimmune.com/

Recent Publications by Avant Immunotherapeutics:
Salmonella Strains with Regulated Delayed Attenuation in Vivo. Recombinant bacterial vaccines must be fully attenuated for animal or...	24th December, 2008	Center for Infectious Diseases and Vaccinology, the Biodesign Institute	Infect Immun. 2008 Dec 22. DOI Direct Link
Co-administration of a CpG adjuvant (VaxImmune(trade mark), CPG 7909) with CETP vaccines increased immunogenicity in rabbits and mice. Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that...	2nd August, 2008	AVANT Immunotherapeutics, Inc., Needham, Massachusetts, USA.	Hum Vaccin. 2008 Jun 29;5(1).
Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli. Enterotoxigenic Escherichia coli (ETEC) is the leading cause of traveler's...	1st April, 2008	AVANT Immunotherapeutics, Inc. 119 Fourth Avenue, Needham, MA 02494,	Vaccine. 2007 Dec 12;25(51):8574-84. Epub 2007 Oct 26. DOI Direct Link
Vaccines for cholesterol management. Over the last 50 years, several attempts have been made to harness the...	28th September, 2007	AVANT Immunotherapeutics Inc., 119 Fourth Ave., Needham, Massachusetts	World J Surg. 2007 Apr;31(4):690-4. DOI Direct Link
Vaccines for the prevention of cardiovascular disease. Atherosclerosis, especially coronary heart disease (CHD), remains a most...	16th February, 2007	AVANT Immunotherapeutics, Inc., 119 Fourth Avenue, Needham, MA 02494, USA.	Vascul Pharmacol. 2006 Nov;45(5):253-7. Epub 2006 Aug 17. DOI Direct Link
→View more Avant Immunotherapeutics research publications.

BioNews Results for Avant Immunotherapeutics:
Clinical Assessment for Management of Dyslipidemia	Current Medical Research and Opinion:  Dec 10 2008 7:10PM Matching: avant immunotherapeutics
Clinical Assessment for Management of Dyslipidemia	Abstracts in Hematology and Oncology:  Dec 10 2008 5:31PM Matching: avant immunotherapeutics
Celldex Reports Third Quarter and Nine Month Financial Results	Pharma Live:  Nov 5 2008 9:34PM Matching: avant immunotherapeutics

Avant Immunotherapeutics Patents:
US Patent No.	Title
7341860	Regulated antigen delivery system (RADS)
6284533	Plasmid-based vaccine for treating atherosclerosis
6261573	Immunoadjuvants
6207171	Polyphosphazene microspheres
6193979	Compositions comprising complement receptor type 1 molecules having carbohydrate structures that are selectin ligands
→View more Avant Immunotherapeutics patents.

Avant Immunotherapeutics (AVAN) Financial information Links from Barchart
AVAN Quote from from Barchart.com
AVAN Chart from from Barchart.com
AVAN Profile from from Barchart.com
AVAN Opinion from from Barchart.com
→View more Avant Immunotherapeutics finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 321 times since April 2007, the link to the organisation's website has been followed 52 times

Recent Search Terms used to find this page: Avant Fourth Avenue Needham ma | avant immunotherapeutics | AVANT Immunotherapeutics rotavirus vaccine patent | Avant Immunotherapeutics | avant immunotherapeutics | .

Search for more companies in Needham

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Avant Immunotherapeutics